Physician profile
Anh Pham
NPI 1437437035
$2,155.08
in general payments reported to CMS, 2019-2025
13 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,297 · 2020: $66.67 · 2021: $289 · 2022: $214 · 2023: $31.63 · 2024: $23.91 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $870.81 | 2019 | |
| Bard Peripheral Vascular, INC. | $198.76 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $194.39 | 2021-2025 | Embold Fibered, Varithena Administration Pack |
| Musculoskeletal Transplant Foundation INC. | $184.25 | 2022 | |
| Cardinal Health 200 LLC | $180.36 | 2019 | |
| Endologix LLC | $165.26 | 2019 | |
| Penumbra, INC. | $159.17 | 2020-2021 | |
| Cordis US Corp. | $50.53 | 2021-2024 | Brite Tip Radianz |
| Shockwave Medical, INC | $37.53 | 2025 | |
| Medtronic, INC. | $36.02 | 2021-2025 | Hawkone |
| Getinge USA Sales, LLC | $27.60 | 2021 | |
| Convatec INC. | $26.67 | 2020 | |
| Abbott Laboratories | $23.73 | 2025 | Emboshield Nav6 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anh Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.